Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02963597 · ClinicalTrials.gov registry record · NA
Auto-PAP for Pulmonary Hypertension Treatment in Decompensated HF Patients With Sleep Apnea.
A NA study, sponsored by Albert Einstein Healthcare Network.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT02963597 is a NA study that has completed, run by Albert Einstein Healthcare Network. The registered enrollment target is 21 participants.
The verdict
NCT02963597, a NA study, has completed, sponsored by Albert Einstein Healthcare Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The objective of the study is to evaluate the effect of continuous positive airway pressure (PAP) therapy on pulmonary arterial (PA) pressures in acute decompensated heart failure (HF) patients with obstructive sleep apnea (OSA). The study will also assess changes in functional parameters, biomarkers, and echocardiographic parameters.
Interventions
- OTHER Standard Medical Therapy
- DEVICE AirSense™ 10 AutoSet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2016-10-01 |
| Est. Completion | 2018-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02963597
The ClinicalTrials.gov registry entry for NCT02963597 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein Healthcare Network, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Medical Therapy is the first listed.
NCT02963597 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02963597 about?
NCT02963597 is a clinical study titled "Auto-PAP for Pulmonary Hypertension Treatment in Decompensated HF Patients With Sleep Apnea.". The objective of the study is to evaluate the effect of continuous positive airway pressure (PAP) therapy on pulmonary arterial (PA) pressures in acute decompensated heart failure (HF) patients with obstructive sleep apnea (OSA). The study will also assess changes in functional parameters, biomarker...
What is the current status of trial NCT02963597?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2016-10-01. Estimated completion is 2018-08-15.
What interventions are being tested in trial NCT02963597?
The interventions under investigation include: Standard Medical Therapy (OTHER), AirSense™ 10 AutoSet (DEVICE).
Who is sponsoring clinical trial NCT02963597?
This trial is sponsored by Albert Einstein Healthcare Network, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.